Galmed Pharmaceuticals : Consolidated Financial Statements - Form 6-K -November 22, 2023 at 04:10 pm EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private...
Source: marketscreener.com
Open Label Part News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Open Label Part. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Open Label Part Today - Breaking & Trending Today
Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results
/PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis...
Source: prnewswire.com
Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects
Recent data reinforce the anti-fibrotic activity of Aramchol previously observed in a wide range of pre-clinical models, in addition to the known effects in...
Source: prnewswire.com
Galmed reports interim results from the Open-Label part of the ARMOR study with Aramchol showing robust fibrosis improvement across multimodality histological assessment
/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...
Source: prnewswire.com
Galmed Announces Positive Results from First 16 Patients in Open-Label Part of ARMOR Study
/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...
Source: prnewswire.com